Roche, under fire, offers compromise in flu drug fight
LONDON (Reuters) - Roche has offered an olive branch to scientific critics in a bid to end a bitter fight over blockbuster flu drug Tamiflu that has led to calls for a boycott of the Swiss drugmaker's products. Tamiflu has been approved by regulators worldwide and stockpiled by many governments in case of a global outbreak - but some researchers claim there is little evidence it works and have lobbied since 2009 for Roche to hand over all its data from clinical trials. Sales of the drug hit close to $3 billion in 2009, due to the H1N1 swine flu pandemic, although they have since declined. ...
Source: news.yahoo.com
No comments:
Post a Comment